NLRP3 and neoplasm: NLRP3 signaling has been shown to promote tumor growth in PDAC [30]; therefore, we hypothesized that the NLRP3-IL1β inflammasome may be activated in the orthotopic model and may contribute to the pro-tumoral immune response.